Skip to main content
Dose-Response logoLink to Dose-Response
. 2018 Feb 2;16(1):1559325818757904. doi: 10.1177/1559325818757904

Correction Notice

PMCID: PMC5802642  PMID: 29497354

Geier DA, Kern JK, Homme KG, Geier MR. Abnormal Brain Connectivity Spectrum Disorders Following Thimerosal Administration: A Prospective Longitudinal Case–Control Assessment of Medical Records in the Vaccine Safety Datalink. Dose Response. 2017;15(1):1–12. https://doi.org/10.1177/1559325817690849

The Declaration of Conflicting Interests statement published in the original article was incomplete and has been corrected and restated with additional information below.

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article:

The authors stated there are no competing financial interests.

Three of the four authors have been involved in vaccine/biologic litigation. Dr. Mark Geier, Mr. David Geier, and Dr. Janet Kern have been involved as consultants and expert witnesses for petitioners in the No-Fault National Vaccine Injury Compensation Program (NVICP) and have also been consultants and expert witness for plaintiffs in civil litigation. The cases that Dr. Janet Kern, Mr. David Geier, and Dr. Mark Geier participated in involved the outcome of autism, and none of the other neurodevelopmental outcomes examined in this study. Dr. Mark Geier and Mr. David Geier are currently involved in no cases, have not been involved in any cases for several years, and have no plans to be involved in any future cases. Dr. Janet Kern is not involved in any current cases and has no plans to be involved in any future cases.

The authors have the following additional professional affiliations with organizations that operate in similar subject areas as the article’s research:

  1. The Institute of Chronic Illnesses, Inc., Silver Spring, MD Mark Geier is President and Co-Director David Geier is Vice President and Co-Director Janet Kern is affiliated

  2. Coalition for Mercury-free Drugs (CoMeD, Inc). David A. Geier is Vice President and Co-Director Mark R. Geier is Treasurer and Co-Director Janet Kern is affiliated

  3. CONEM US Autism Research Group in Allen, Texas (Council for Nutritional and Environmental Medicine) Janet Kern is Head

  4. Council for Nutritional and Environmental Medicine (http://www.conem.org) Janet Kern is a Director on the Board of Directors

  5. International Academy of Oral Medicine and Toxicology, ChampionsGate, FL, USA Kristin G. Homme is affiliated

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the non-profit 501(c)(3) Institute of Chronic Illnesses, Inc and the non-profit 501(c)(3) CoMeD, Inc.


Articles from Dose-Response are provided here courtesy of SAGE Publications

RESOURCES